Mitchell KG, Farooqi A, Ludmir EB, Corsini EM, Zhang J, Sepesi B, Vaporciyan AA, Swisher SG , Heymach JV, Zhang J, Gomez DR, Antonoff MB
The groups were composed as follows: group 1, 71 varicoceles and 47 idiopathic OATs
Individuals considering GLP-1 agonists for binge eating disorder should engage in thorough, collaborative discussions with healthcare providers who understand both the medications and eating disorders
Work with an interdisciplinary team to tackle thorny problems
Semaglutides side effects
However, in routine clinical practice, changes in eating experience are often reported subjectively (76), and may be difficult to distinguish from olfactory changes, xerostomia, or gastrointestinal discomfort (68, 77), thereby compromising the precision of endpoint definition